UK markets closed

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
742.90-5.90 (-0.79%)
At close: 04:59PM CEST
Full screen
Previous close748.80
Bid738.90 x 0
Ask742.90 x 0
Day's range737.20 - 755.00
52-week range475.45 - 834.50
Avg. volume2,075,988
Market cap1.684T
Beta (5Y monthly)0.32
PE ratio (TTM)34.55
EPS (TTM)21.50
Earnings dateN/A
Forward dividend & yield10.40 (1.39%)
Ex-dividend date25 Mar 2022
1y target est784.25
  • Globe Newswire

    Novo Nordisk A/S: Share repurchase programme

    Bagsværd, Denmark, 16 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme initiate

  • Zacks

    Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA Nod

    Lilly's (LLY) Mounjaro (tirzepatide) is a novel diabetes treatment, which has shown impressive blood sugar reductions and weight loss in a broad range of type II diabetes patients in the SURPASS studies.

  • Stockopedia

    Assessing the impact of economic shocks on the Novo Nordisk A/S share price

    A question on the minds of many investors right now is how economic uncertainty will continue to affect large cap companies, such as Novo Nordisk A/S (CPH:NOVO...